InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: Marksch1 post# 80492

Tuesday, 05/26/2020 4:59:00 PM

Tuesday, May 26, 2020 4:59:00 PM

Post# of 232883
Yes the protocol has slowed enrollment. That is a negative.

The positive is the FDA will get what they requested and it’s going to show the strength of Leronlimab as a stand alone treatment.

In the face of frustration shareholders would be wise to exercise patience. It will be handsomely rewarded.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News